Cite
Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus.
MLA
Freo, U., et al. “Adrenalectomy or Metyrapone-Pretreatment Abolishes Cerebral Metabolic Responses to the Serotonin Agonist 1-(2,5-Dimethoxy-4-Iodophenyl)-2-Aminopropane (DOI) in the Hippocampus.” Brain Research, vol. 586, no. 2, July 1992, pp. 256–64. EBSCOhost, https://doi.org/10.1016/0006-8993(92)91634-q.
APA
Freo, U., Holloway, H. W., Kalogeras, K., Rapoport, S. I., & Soncrant, T. T. (1992). Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus. Brain Research, 586(2), 256–264. https://doi.org/10.1016/0006-8993(92)91634-q
Chicago
Freo, U, H W Holloway, K Kalogeras, S I Rapoport, and T T Soncrant. 1992. “Adrenalectomy or Metyrapone-Pretreatment Abolishes Cerebral Metabolic Responses to the Serotonin Agonist 1-(2,5-Dimethoxy-4-Iodophenyl)-2-Aminopropane (DOI) in the Hippocampus.” Brain Research 586 (2): 256–64. doi:10.1016/0006-8993(92)91634-q.